Johnson & Johnson has created a subsidiary to manage thousands of legal claims alleging its talc caused cancer and placed it into Chapter 11 bankruptcy, in a move critics say is aimed at limiting future payouts.
The New Jersey-based drugmaker said on Thursday the filing by its subsidiary, LTL Management, was intended “to resolve all claims related to cosmetic talc in a manner that is equitable to all parties, including any current and future claimants”.
However, legal experts said the manoeuvre could potentially put a stay on pending cases, prevent juries from awarding big payouts to plaintiffs and pressure cancer sufferers into accepting settlements.
您已閱讀26%（657字），剩余74%（1887字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。